NICE has issued the first UK guidance for the treatment of primary mitochondrial myopathies (PMOS), a rare and complex condition affecting the muscles. Learn mo
NICE has issued the first UK guidance for the treatment of primary mitochondrial myopathies (PMOS), a rare and complex condition affecting the muscles. Learn mo